News and History
Life Science News and History
LifeScienceHistory.com (LSH), “Where history is made daily” is a comprehensive compendium of life science. Simply put, we dig history and we mine data daily.
LSH grew from frustration with the difficulty in finding historical information about life science, and the industry in general. Most seemed to be the same old duped lists of facts, rarely with images, nor links for more information, and almost never sourced.
LSH news and history are presented in an easily readable format with images, all sourced, linked and content updated where possible, because history is made daily. You can also search by state, province or nation, and find information about your locale. Plus you can search our one-of-a-kind ‘Genealogy on Demand‘ and see what companies are spin-offs from universities and non-profit organizations in your state or province.
We invite you to Sign up for our monthly E-history for news, history and original cartoons, and our mid month Spotlight highlighting select topics of interest.
-

US loses measles elimination status after nearly three decades
Read More: US loses measles elimination status after nearly three decadesOn Nov. 17, 2026, the United States lost its hard-fought measles elimination status after 26 years, the Pan American Health Organization said on Tuesday,…
-

Supreme Court rejects Trump bid to revive University of California research grant cuts
Read More: Supreme Court rejects Trump bid to revive University of California research grant cutsOn Nov. 16, 2026, The Supreme Court declined to hear a petition from the Trump administration to review a temporary block on its effort…
-

Johnson & Johnson to acquire Ollin Biosciences and late-stage bispecific antibody with potential in ophthalmology for $2.2 billion
Read More: Johnson & Johnson to acquire Ollin Biosciences and late-stage bispecific antibody with potential in ophthalmology for $2.2 billionOn Nov. 16, 2026, Johnson & Johnson announced it has entered into a definitive agreement to acquire Ollin Biosciences a clinical-stage biopharmaceutical company developing…
-

Leading biologist leaves University of Chicago after three decades to join China’s Zhejiang University
Read More: Leading biologist leaves University of Chicago after three decades to join China’s Zhejiang UniversityOn Nov. 16, 2026, biologist Zhao Yingming, whose research has produced more than 210 scientific papers, has left the University of Chicago for Zhejiang…
-

University of Colorado Study Identified Kidney Protein Protects Blood Vessels
Read More: University of Colorado Study Identified Kidney Protein Protects Blood VesselsOn Nov. 16, 2026, Researchers at the University of Colorado Anschutz School of Medicine announced they have discovered a protein in the kidneys that…
-

FDA approves Roche’s Wilserdly (giredestrant), a next-generation oral SERD, for ER-positive, ESR1-mutated advanced breast cancer
Read More: FDA approves Roche’s Wilserdly (giredestrant), a next-generation oral SERD, for ER-positive, ESR1-mutated advanced breast cancerOn Nov. 15, 2026, Roche announced that the U.S. Food and Drug Administration (FDA) has approved Wilserdly™ (giredestrant) in combination with everolimus for the…
-

128 confirmed New World Screwworm cases across Southwestern U.S. states
Read More: 128 confirmed New World Screwworm cases across Southwestern U.S. statesOn Nov. 12, 2026, The U.S. Department of Agriculture is reporting 128 confirmed cases of New World Screwworm. The confirmed cases are in Texas,…
-

Lilly secures first oral GLP-1 obesity approval in China
Read More: Lilly secures first oral GLP-1 obesity approval in ChinaOn Nov. 12, 2026, Eli Lilly announced it has received regulatory approval in China for its oral glucagon-like peptide-1 (GLP-1) receptor agonist, orforglipron, marking…
-

Scientists create landmark cellular atlas of one of the brain’s most important regions
Read More: Scientists create landmark cellular atlas of one of the brain’s most important regionsOn Nov. 12, 2026, in a massive, collaborative effort, dozens of labs and hundreds of scientists working together across nine countries and more than…
-

Novo commits USD $200 million to World Diabetes Foundation
Read More: Novo commits USD $200 million to World Diabetes FoundationOn Nov. 11, 2026, Novo announced it has committed USD $200 million to the World Diabetes Foundation (WDF) for 2027–2036. The funding will support…
-

Moderna Announces Publication of Real-World Comparative Effectiveness Data for COVID-19 Vaccine, mRNA in Adults Aged 65 Years and Older
Read More: Moderna Announces Publication of Real-World Comparative Effectiveness Data for COVID-19 Vaccine, mRNA in Adults Aged 65 Years and OlderOn Nov. 11, 2026, Moderna announced the publication of results from a large real-world study evaluating the comparative effectiveness of mNEXSPIKE® (COVID-19 Vaccine, mRNA)…
-

First Detection of Highly Pathogenic Avian Influenza in Oregon Dairy Cattle Confirmed
Read More: First Detection of Highly Pathogenic Avian Influenza in Oregon Dairy Cattle ConfirmedOn Nov. 10, 2026, Preliminary detection of HPAI was identified through Oregon’s routine statewide milk surveillance program, with preliminary results reported by the Oregon…
-

Virtuoso Surgical Receives FDA De Novo Authorization for Its Robotic System for En Bloc Resection of Bladder Lesions
Read More: Virtuoso Surgical Receives FDA De Novo Authorization for Its Robotic System for En Bloc Resection of Bladder LesionsOn Nov. 10, 2026, Virtuoso Surgical, the developer of miniaturized robotic tools for endoscopic surgery, announced that the U.S. Food and Drug Administration (FDA)…
-

Stanford University Life Science Genealogy Poster Released
Read More: Stanford University Life Science Genealogy Poster ReleasedOn Nov. 9, 2026, LifeScienceHistory.com (LSH) published a poster from “Genealogy on Demand” that illustrates spin-off companies from Stanford University, a private research university…
-

Oregon Life Science Genealogy Poster Released
Read More: Oregon Life Science Genealogy Poster ReleasedOn Nov. 9, 2026, LifeScienceHistory.com (LSH) published a poster from “Genealogy on Demand” that illustrates spin-off companies originating from university and non-profit research organizations…
-

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk
Read More: FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High RiskOn Nov. 9, 2026, the U.S. Food and Drug Administration (FDA) approved Bayer’s Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor…
-

LifeScienceHistory.com Releases Life Science Genealogy Poster for University of California, Berkeley
Read More: LifeScienceHistory.com Releases Life Science Genealogy Poster for University of California, BerkeleyOn Nov. 8, 2026, LifeScienceHistory.com (LSH) published a poster from “Genealogy on Demand” that illustrates spin-off companies originating from the University of California, Berkeley.…
-

Genealogy Poster Illustrates Spin-Off Companies from Washington’s Universities and Non-Profit Research Organizations
Read More: Genealogy Poster Illustrates Spin-Off Companies from Washington’s Universities and Non-Profit Research OrganizationsOn Nov. 7, 2026, a Life Science Genealogy poster from “Genealogy on Demand” that illustrates spin-off companies from Washington’s Universities and Non-Profit Research Organizations…
-

LifeScienceHistory.com Releases University of Washington Life Science Genealogy Poster
Read More: LifeScienceHistory.com Releases University of Washington Life Science Genealogy PosterOn Nov. 6, 2026, LifeScienceHistory.com (LSH) published a poster from “Genealogy on Demand” that illustrates spin-off companies from the University of Washington located in…
-

Arizona Life Science Genealogy Published by LifeScienceHistory.com
Read More: Arizona Life Science Genealogy Published by LifeScienceHistory.comOn Nov. 6, 2026, Arizona Life Science Genealogy was published by LifeScienceHistory.com (LSH) illustrating life science companies that are spin-offs from ‘universities and non-profit…




